cgp 28392 has been researched along with fluspirilene in 1 studies
Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (fluspirilene) | Trials (fluspirilene) | Recent Studies (post-2010) (fluspirilene) |
---|---|---|---|---|---|
76 | 1 | 2 | 155 | 17 | 33 |
Protein | Taxonomy | cgp 28392 (IC50) | fluspirilene (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 10 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fraser, S; Kenny, BA; Kilpatrick, AT; Spedding, M | 1 |
1 other study(ies) available for cgp 28392 and fluspirilene
Article | Year |
---|---|
Selective antagonism of calcium channel activators by fluspirilene.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Binding, Competitive; Calcium Channel Agonists; Calcium Channel Blockers; Cecum; Cerebral Cortex; Female; Fluspirilene; Guinea Pigs; In Vitro Techniques; Isradipine; Kinetics; Muscle, Smooth; Oxadiazoles; Potassium; Pyridines; Radioligand Assay; Spiro Compounds | 1990 |